The Mitochondrial Dysfunction Hypothesis in Autism Spectrum Disorders: Current Status and Future Perspectives.

Area of Science:

• Neurodevelopmental disorders
• Genetics
• Mitochondrial biology

Background:

• Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions with significant genetic variability.
• Metabolic profiles in ASD patients suggest potential involvement of mitochondrial pathways.
• Previous studies indicated deficits in mitochondrial oxidative phosphorylation in individuals with ASD.

Purpose of the Study:

• To review and synthesize recent evidence on the role of mitochondrial disorders in ASD development.
• To highlight the under-explored area of mitochondrial DNA variations in ASD.

Main Methods:

• Literature review of recent scientific evidence.
• Discussion of physiological and biochemical studies.
• Analysis of genetic and metabolic data related to ASD and mitochondrial function.

Main Results:

• Growing evidence points to a significant role of mitochondrial dysfunction in ASD.
• Mitochondrial DNA variations represent a critical, yet underexplored, factor in ASD etiology.
• Deficits in oxidative phosphorylation are consistently observed in ASD subjects.

Conclusions:

• Mitochondrial disorders are increasingly recognized as a key factor in the pathogenesis of autism spectrum disorders.
• Further research into mitochondrial DNA variations is crucial for understanding ASD.
• Targeting mitochondrial pathways may offer novel therapeutic strategies for ASD.